| |
|
|
|
Galectin Therapeutic  
|
|
2.61 -0.04 (-0.02%) |
11-30 15:36 |
|
Open: |
2.6 |
Pre close: |
2.65 |
Target:
|
3.15 
|
|
High: |
2.64 |
Low: |
2.57 |
Resistance:
|
2.70
2.85
|
|
Volume: |
115,830 |
Market Cap: |
149M |
Support:
|
2.45
2.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.61
|
MACD |
MACD(12,26):
|
-0.02  |
|
MA(20): |
2.64 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
2.74 |
Stochastic Oscillator |
%K(14,3):
|
37.14 |
|
MA(250): |
2.62 |
%D(3): |
33.33 |
|
Average Volume(K) |
3-Month: |
30978
|
52-Week |
High:
|
3.85 |
|
10-Days: |
13690 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
48.42 |
Change(%): |
-17.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.391 |
Return on Equity (ttm) |
-51.2 |
Shares Out. (M) |
57.08 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-30.7 |
Shares Float (M) |
41.12 |
|
EPS Est. Next Year |
-0.520 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.97 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.56 |
|
Forward EPS |
-0.380 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5230 |
|
Book Value (p.s.) |
0.510 |
EBITDA (p.s.) |
0.000 |
P/E |
-6.73 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.30 |
P/CF |
-7.92 |
|
|
|
|
|
|
